


The Fund aims to provide a high level of income together with long term capital growth.
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline PLC | 4.0% |
| Diageo PLC | 3.7% |
| Babcock International Group PLC | 3.2% |
| Cable & Wireless PLC | 2.8% |
| Smith & Nephew PLC | 2.8% |
| Unilever PLC | 2.6% |
| Melrose PLC | 2.5% |
| Chemring Group PLC | 2.2% |
| VT Group PLC | 2.2% |
| Reed Elsevier PLC | 2.2% |
| Key | % Net Assets |
|---|---|
| 4.0% | |
| 3.7% | |
| 3.2% | |
| 2.8% | |
| 86.3% |
| Date | 18-Jun-2025 |
|---|---|
| NAV | 174.50p |
| Currency | GBP |
| Change | -4.10p |
| % | -2.30% |
| YTD change | 11.70p |
| YTD % | 7.19% |
| Fund Inception | 06/05/2005 |
|---|---|
| Fund Manager | Matt Hudson |
| TER | 1.23 (30-Apr-2011) |
| Minimum Investment | |
|---|---|
| Initial | £25000 |
| Additional | £500 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.07 |
You are here: research